About the survey
A total of 266 leading health insurers representing 66 countries participated in our 2024 Global Medical Trends Survey, which was conducted in July 2023. To lessen the effect of market size and currency issues, we have weighted regional and global trend rates using GDP per capita.
Near double-digit global medical costs projected in 2024, despite decline from 2023 highs
The cost of medical care globally reached a historic high in 2023, with the medical trend rate climbing into the double digits for the first time. However, the WTW 2024 Global Medical Trends Survey reveals a near-term improvement in trend — while longer-term challenges persist. After surging from 7.4% in 2022 to a high of 10.7% in 2023, the medical cost trend for 2024 is projected to decrease to a global average of 9.9%.
Several factors are contributing to this decline. The spike in elective procedures, consultations and other medical care resulting from delayed or postponed care due to the pandemic is starting to ease. In addition, global inflation, which was a significant factor in driving up healthcare costs, is expected to continue to fall in 2024.
The spike in elective procedures, consultations and other care resulting from delayed or postponed care due to the pandemic is starting to ease.
But while medical trend is projected to decline, it remains elevated, partly due to the high cost of new medical technologies. Furthermore, in some regions, ongoing geopolitical conflicts and resulting displaced populations have driven up medical costs due to an increased need for care and reduced availability of providers.
The growth in medical costs is projected to decline further or remain unchanged in most regions in 2024 (Figure 1). Healthcare insurers participating in our survey expect the sharpest decrease to occur in Europe, where medical trend is projected to drop from 10.9% in 2023 to 9.3% in 2024, the lowest rate of increase projected in any region. While this decline is encouraging, Europe has traditionally seen much lower levels of trend. The stubbornly high medical trend in Europe can be attributed primarily to higher healthcare cost increases in countries in Eastern Europe and in Turkey.
Global medical trend 2022 – 2024, globally and by region
| Gross | Net** | |||||
|---|---|---|---|---|---|---|
| 2022 | 2023 | 2024 (projected) | 2022 | 2023 | 2024 (projected) | |
| Global | 7.4 | 10.7 | 9.9 | –0.3 | 5.2 | 6.5 |
| Latin America | 10.5 | 12.4 | 11.6 | 2.7 | 6.3 | 7.9 |
| North America | 8.0 | 9.8 | 9.4 | 0.5 | 5.6 | 7.1 |
| Asia Pacific | 7.2 | 9.9 | 9.9 | 2.2 | 5.6 | 7.0 |
| Europe | 6.7 | 10.9 | 9.3 | –2.4 | 5.0 | 5.9 |
| Middle East and Africa | 9.8 | 11.3 | 12.1 | 2.6 | 4.2 | 6.8 |
The growth in medical costs is projected to decline
further or remain unchanged in most regions in 2024.
Global and Latin America numbers exclude Argentina and
Venezuela **Net of general inflation
The growth in medical trend in Latin America is expected to decrease from 12.4% to 11.6%, while in Asia Pacific, the trend rate is projected to remain unchanged at 9.9%. In North America, it is anticipated that medical trend will drop from 9.8% to 9.4%, due in large part to abating inflation. In the Middle East and Africa, insurers expect trend to increase slightly from 11.3% to 12.1%.
Medical costs are expected to rise over the longer term
While the growth in medical trend is projected to slow globally in 2024, insurers expect costs to resume their ascent over the longer term. Over half of insurers (58%) anticipate higher or significantly higher medical trend over the next three years. Eighty-four percent of insurers in the Middle East and Africa expect higher or significantly higher healthcare cost increases during this time period as do over half of insurers in Europe (57%) and Asia Pacific (59%); however, in the Americas, less than half of insurers (45%) anticipate this level of cost increase.
58% of insurers anticipate higher or significantly higher medical trend over the next three years.
Key findings
Our survey uncovers the key factors influencing medical trend rates and opportunities to control costs.
- More insurers cite musculoskeletal disorders as a top condition by incidence. Mental health ranks among the fastest-growing conditions by incidence and cost. Musculoskeletal disorders remain the top condition by incidence of claims, followed by cardiovascular disease and cancer. Poor ergonomics in employees' home work environments and a sedentary lifestyle are key factors contributing to musculoskeletal disorders. Employees also continue to struggle with mental health issues, including anxiety and depression, which can affect overall employee wellbeing and productivity. Mental and behavioral health disorders are expected to remain among the top five fastest-growing conditions by both cost and claims over the next 18 months. In the Americas, mental health is the top condition by incidence of claims.
Mental and behavioral health disorders are expected to remain among the top five fastest-growing conditions by both cost and claims.
Mental and behavioral health disorders are expected to remain among the top five fastest-growing conditions by both cost and claims.
- New medical technologies and overuse of care drive healthcare spend. The use of new medical technologies ranging from artificial intelligence-powered diagnostic tools to gene therapy remains the leading external factor contributing to increased medical costs. This is particularly the case in Asia Pacific, where rapid development of medical technologies has occurred in an effort to catch up with other regions. Additionally, insurers continue to be concerned about overuse of care due to providers recommending too many services, which is the leading factor driving up medical costs per person. This commonly occurs where systems are overburdened and providers have limited time to spend with patients. But there is progress on this front. The percentage of insurers that regard overuse of care as a significant cost driver declined from three-quarters (74%) in 2022 to 59% in 2023. This decline may be due to the easing of the surge in care following the COVID-19 shutdown, which likely contributed to overuse of care.
- Exclusions and other variations in healthcare programs thwart the impact of wellbeing and DEI initiatives. In regions such as Asia Pacific and the Middle East and Africa, many organizations' medical insurance programs continue to exclude coverage for treatment of certain conditions for which treatments exist and despite a recognized need for care among the insured population. These exclusions — which include drug and alcohol abuse treatments, HIV/AIDS medications, fertility treatments and gender-affirming care — can significantly affect employee wellbeing and diversity, equity and inclusion (DEI) efforts. Insurers are increasingly interested in expanding eligibility in these programs to be more inclusive, but legal or major sociocultural considerations in some countries pose barriers to change. Public healthcare systems in other regions have embedded inclusion and widespread program eligibility in their scope of coverage; however, in countries with public systems where quality of and access to care have deteriorated, coverage gaps exist, and private insurers have not yet caught up to these needs.
The decline in the quality and funding of public healthcare systems has increased as a top driver of private medical costs.
- Weakened public healthcare systems put more pressure on private insurers and providers. The decline in the quality and funding of public healthcare systems has increased as a top driver of private medical costs, from 27% in 2022 to 34% in 2023. Public healthcare systems are facing major challenges due to geopolitical conflicts, inflation and risks of a global recession. Moreover, many of these systems face a backlog of scheduled procedures that resulted from the COVID-19 pandemic. At the same time, the number of medical practitioners and staff in social healthcare systems has reportedly declined in many local markets, contributing to lengthy wait times. Consequently, the demand for private healthcare to bridge the gaps within public systems is higher than ever. To fulfill this demand, private insurers are continuing to contract with local networks of providers and facilities. The prevalence of contracting with networks has increased from 2022, reflecting the growing need to provide healthcare at competitive rates.
- Telehealth offerings continue to be a priority for insurers. In 2023, 40% of insurance organizations globally added telehealth services, making this one of the top coverage changes insurers are making to their medical portfolios. Telehealth has redefined and improved healthcare delivery by providing speedy and efficient access to a range of medical services, including primary care and specialist care, prescription drugs, mental and behavioral health programs, and care navigation support for acute illnesses. Additionally, insurers recognize that telehealth provides opportunities to manage healthcare costs more effectively. Telehealth and virtual care help reduce the need for costly emergency room visits and provide cost-efficient access to specialists, especially in the area of mental health. While the use of telehealth globally continues to rise, there is considerable variation across regions in the medical services delivered through telehealth. Member preferences also vary. In some countries, members are utilizing healthcare more than ever due to the accessibility that virtual care affords. In others, there is a noted member preference for in-person care. But our Global Benefits Attitude Survey shows that employees globally view virtual consultations favorably in comparison to in-person consultations.
Download the executive summary for access to the global medical trends by market and actions to take to gain a competitive advantage through your healthcare benefits.
To view the full article, click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
